DRIVe EZ-BAA

Synopsis
The Pandemic and All Hazard Preparedness Act Pub. L. No. 109-417, 42 U.S.C. § 241 et seq. (PAHPA: http://www.gpo.gov/fdsys/pkg/PLAW-109publ417/pdf/PLAW-109publ417.pdf) and The Pandemic and All Hazard Preparedness Reauthorization Act Pub. L. No. 114-255, (PAHPRA: https://www.congress.gov/bill/114th-congress/house-bill/34/text) authorizes the Office of Biomedical Advanced Research and Development Authority (BARDA) to accelerate innovations and improve the availability of transformative products and technologies to protect Americans from natural and intentional health security threats by soliciting revolutionary technologies and innovations in health security to meet DRIVe's Mission.
The purpose of this Broad Agency Announcement (BAA) is to solicit abstracts that focus on one or more of the following areas of interest as listed here and further described in Part VI.
DRIVe's Areas of Interest include:

1. Early Notification to Act, Control and Treat (ENACT)
2. Save lives by Solving Sepsis
3. Other Innovative Products with potential to radically transform Health Security

Note: The previous Pre-solicitation Title: BAA-18-BARDA DRIVe-SOL-00018 is change to BAA-18-100-SOL-00018. Additional information about DRIVe can be found at www.drive.hhs.gov.
The Government intends to have a Full & Open competition for this requirement in the form of a BAA. This synopsis is not a BAA; a BAA itself is anticipated to be posted on June 4, 2018. The Government expects to make one or more awards, subject to the availability of funds. The open period of the BAA will be specified in the BAA itself.
Pre-proposal Conference:
A BAA Pre-Proposal teleconference is scheduled for June 22, 2018, at 2:00PM EDT. For additional information, please visit www.drive.hhs.gov.
Contact Information:
Comments to this announcement, referencing synopsis BAA-18-100-SOL-00018, may be submitted to the following email address: DRIVeContracting@HHS.gov.